Singapore markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
146.10-3.90 (-2.60%)
At close: 04:00PM EDT
145.88 -0.22 (-0.15%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close150.00
Bid145.38 x 800
Ask146.10 x 1400
Day's range144.99 - 150.75
52-week range115.61 - 464.85
Avg. volume5,165,193
Market cap57.154B
Beta (5Y monthly)1.60
PE ratio (TTM)4.98
EPS (TTM)29.35
Earnings date02 Nov 2022 - 07 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est221.40
  • Motley Fool

    Why Moderna Was Sinking This Week

    The biotech's shares had lost nearly 15% of their value week to date as of mid-afternoon Friday, according to S&P Global Market Intelligence. On Thursday, The Wall Street Journal published an article stating that the government is planning to end its financial support for coronavirus vaccines and COVID-19 treatments. Although the coronavirus is still very much with us, cases in many jurisdictions -- such as the U.S. -- have been dropping, at times precipitously.

  • Motley Fool

    Why Moderna Stock Was Wilting on Wednesday

    Is star coronavirus stock Moderna (NASDAQ: MRNA) beginning a new phase of its late-pandemic life? This might have been a concern of investors after the company announced Wednesday morning that David Meline, who has served as CFO since nearly the start of the pandemic, is stepping down from the company. After all, Meline guided Moderna to a series of impressive quarterly beats on the back of the successful coronavirus vaccine the company developed and brought to market.

  • Yahoo Finance

    U.S. to end purchase of COVID-19 vaccines as industry pivots to commercial market

    Vaccines, treatments and tests will soon all be commercially available. But what that means for consumers' out-of-pocket costs is unclear.